Works matching IS 21641153 AND DT 2022 AND VI 12 AND IP 3
Results: 14
Peptide-Based CoVac-1 Vaccine Shows Promise Against COVID-19 in Patients with Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 166
- Publication type:
- Article
First-Line Sotorasib Shows Long-Lasting Responses in Metastatic NSCLC with KRAS Mutation.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 165
- Publication type:
- Article
Genetic Score Makes PSA Screening More Accurate.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 164
- Publication type:
- Article
New Standards of Care for Melanoma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 162
- Publication type:
- Article
NCCN Guidelines Update: Initial Colorectal Screening Lowered to Age 45.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 161
- Publication type:
- Article
New Oncology Drugs and New Indications Approved by the FDA.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 158
- Publication type:
- Article
Managing Resistant Fusarium Infections in Immunocompromised Pediatric Patients with Malignancy: 2 Case Reports and Review of the Literature.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 151
- By:
- Publication type:
- Article
Vancomycin Infusion Reaction: A Clinical and Therapeutic Overview.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 146
- By:
- Publication type:
- Article
Reduced Starting Dose of Tyrosine Kinase Inhibitors in Patients with Metastatic Renal-Cell Carcinoma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 138
- By:
- Publication type:
- Article
Evaluation of Clinical Pharmacy Services for Phase 1 Clinical Trials.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 131
- By:
- Publication type:
- Article
Pharmacist-Driven Intervention Significantly Increases Biosimilar Adoption in Clinical Practice.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 129
- Publication type:
- Article
Oncologists' Common Misconceptions About Biosimilars Revealed in a Recent Survey.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 128
- Publication type:
- Article
Adoption of Biosimilars--Why the Delay?
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 117
- By:
- Publication type:
- Article
Comparing Single-Center Outcomes Between Reference and Biosimilar Granulocyte Colony-Stimulating Factor Drugs Used for Autologous Stem-Cell Mobilization.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 119
- By:
- Publication type:
- Article